Zoetis Inc.
NYSE:ZTS
175.67 (USD) • At close February 5, 2025
Overzicht | Financiële gegevens
Bedrijfsnaam | Zoetis Inc. |
Symbool | ZTS |
Munteenheid | USD |
Prijs | 175.67 |
Beurswaarde | 79,256,155,550 |
Dividendpercentage | 0.96% |
52-weken bereik | 144.8 - 200.53 |
Industrie | Drug Manufacturers—Specialty & Generic |
Sector | Healthcare |
CEO | Ms. Kristin C. Peck |
Website | https://www.zoetis.com |
An error occurred while fetching data.
Over Zoetis Inc.
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. The company also offers vaccines, which
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (USD)
Cijfers zijn in miljoenen (USD)